Your session is about to expire
← Back to Search
Hydrochlorothiazide for Polycystic Kidney Disease (HYDRO-PROTECT Trial)
HYDRO-PROTECT Trial Summary
This trial will test whether a V2R antagonist, tolvaptan, can be more effective in treating ADPKD when co-administered with hydrochlorothiazide.
HYDRO-PROTECT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowHYDRO-PROTECT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HYDRO-PROTECT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have low blood pressure or feel dizzy when standing up.I have had gout attacks more than twice last year and am on preventive medication.I have been on a stable dose of my heart medication for at least 3 months.My blood pressure is not higher than 160/100 mmHg.I have had skin cancer before.I have been diagnosed with ADPKD.You are allergic to hydrochlorothiazide.I am currently taking water pills.I am 18 years old or older.Your kidney function is better than a certain level.Your blood potassium level is too low.
- Group 1: Hydrochlorothiazide
- Group 2: Placebo
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there long-term repercussions to taking Hydrochlorothiazide?
"Hydrochlorothiazide has received a safety score of 3 from our analysts at Power. This is due to the fact that it is a Phase 3 trial, and thus has both evidence of efficacy and multiple rounds of safety data."
Which type of patient do you think would respond best to this treatment?
"This study is for adults aged 18-80 who have been diagnosed with kidney disease. They are looking to enroll 300 total participants."
Are people with the necessary qualifications currently able to enroll in this clinical trial?
"No, this research is not presently looking for volunteers. However, this may change in the future as the study was last updated on May 10th, 2022. Additionally, there are 499 other trials that are currently enrolling patients."
Does this research allow for volunteers who are older than 55 years of age?
"Patients that meet the age requirement of 18-80 years old are eligible for this clinical trial. There are 43 other trials for patients that are younger and 458 for seniors."
Share this study with friends
Copy Link
Messenger